Frankfurt
22.11.24
08:11 Uhr
0,003 Euro
0,000
-3,23 %
-3,23 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 11.11. | Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024 | 1 | Cision News | ||
| 25.10. | Episurf Medical AB: Interim Report 1 January - 30 September 2024 | 47 | GlobeNewswire (Europe) | Improvement of financial result through lower cost base and increased revenues
Focus towards expansion of US sales force
Continued progress of 510(k)-process for great toe implant
"I am pleased... ► Artikel lesen | |
| 01.10. | Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2025 | 1 | Cision News | ||
| 24.09. | Niles Noblitt, through Sacajo Investments LLC, makes investment in Episurf through an arrangement with CEO Pål Ryfors | 4 | Cision News | ||
| 24.09. | Episurf Medical: Update on 510(k) application for big toe implant | 2 | Cision News | ||
| 19.09. | Episurf Medical to present at Pareto Securities Healthcare Conference on September 19, 2024 | 1 | Cision News | ||
| 27.08. | EPISURF: Episealer® technology to be presented at international scientific congress | 3 | Cision News | ||
| 12.07. | EPISURF: INTERIM REPORT 1 JANUARY - 30 JUNE 2024 | 3 | Cision News | ||
| 12.07. | Episurf Medical AB: Interim Report 1 January - 30 June 2024 | 91 | GlobeNewswire (Europe) | 45% sales growth despite transformation of sales organization
Additional SEK 12m in annual cost savings identified
Pause of EPIC-Knee trial to the advantage of other initiatives
"We have started... ► Artikel lesen | |
| 28.06. | Change in number of shares and votes in Episurf Medical | 1 | Cision News | ||
| 27.06. | Nasdaq Stockholm AB: New equity right for trading, Episurf Medical AB TO 13 | 260 | GlobeNewswire | At the request of Episurf Medical AB , Episurf Medical AB equity rights will be
traded on First North Growth Market as from June 28, 2024.
Security name: Episurf Medical AB TO 13
----------------------------------------
Short... ► Artikel lesen | |
| 17.06. | Episurf Medical resolves on an issue of units to guarantors in connection with the completed rights issue | 3 | Cision News | ||
| 13.06. | Episurf Medical announces outcome of the rights issue | 3 | Cision News | ||
| 30.05. | Episurf Medical to present at Redeye Growth Day today, May 30[th], 2024 | 4 | Cision News | ||
| 27.05. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Episurf Medical AB | 386 | GlobeNewswire | With effect from May 28, 2024, the unit rights in Nasdaq will be traded on the
list for Equity rights. Trading will continue up until and including June 07,
2024.
Instrument: Unit rights ... ► Artikel lesen | |
| 24.05. | Episurf Medical AB: Episurf Medical publishes prospectus in connection with the company's partially guaranteed rights issue of up to approximately SEK 120 million | 346 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA... ► Artikel lesen | |
| 22.05. | Episurf Medical AB: Summary From The Extraordinary General Meeting Of Episurf Medical AB (publ) | 100 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 22 May 2024 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen | |
| 22.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 22.05.2024 | 888 | Xetra Newsboard | Das Instrument A07 BMG067231032 AVANCE GAS HLDG DL 2 EQUITY wird cum Kapitalmassnahme gehandelt am 22.05.2024 und ex Kapitalmassnahme am 23.05.2024 The instrument A07 BMG067231032 AVANCE GAS HLDG DL... ► Artikel lesen | |
| 24.04. | Episurf Medical AB: Interim report 1 January - 31 March 2024 | 212 | GlobeNewswire (Europe) | • Reduced cost base following implementation of restructuring programme
• Ongoing regulatory process targeting 510(k)-clearance Episealer® MTP-System
• Largest distribution agreement to date in the... ► Artikel lesen | |
| 09.02. | Episurf Medical AB: Year-End Report 1 January - 31 December 2023 | 92 | GlobeNewswire (Europe) | Continued stable growth despite restructuring of commercial organization, and satisfactory start in the US with significant opportunities ahead
Restructuring program completed with planned cost... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 0,795 | +1,92 % | Imunon, Inc.: IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting | IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was... ► Artikel lesen | |
| ELECTROCORE | 10,600 | +12,17 % | electroCore, Inc.: electroCore's Truvaga Plus Wins Woman's World Magazine 50 over 50 Award | ||
| FRESENIUS | 33,310 | +1,59 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 49,800 | +1,36 % | Siemens Healthineers Aktie: Fortschrittliches Denken zahlt sich aus! | Die Siemens Healthineers-Aktie verzeichnete am Handelstag eine erfreuliche Entwicklung mit einem Kursgewinn von 1,5 Prozent auf 49,86 Euro im XETRA-Handel. Im Tagesverlauf erreichte das Papier sein... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 42,250 | +1,95 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 49 auf 52 Euro angehoben und die Einstufung auf "Buy" belassen. Die Ergebnisse des dritten Quartals seien... ► Artikel lesen | |
| GERRESHEIMER | 73,85 | +4,83 % | Gerresheimer, Lanxess, SMA Solar, ThyssenKrupp, TUI, Wacker Chemie u.a. - Aktien-Positionen der Wacker Chemie | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 55,45 | +1,46 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
| PROGYNY | 15,440 | +3,17 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| ECKERT & ZIEGLER | 39,880 | +7,84 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 55 Euro auf "Buy" belassen. Das Auftragsbuch erscheine vielversprechend... ► Artikel lesen | |
| TEMPUS AI | 58,59 | +11,64 % | Cathie Wood's ARK buys Tempus AI stock, sells Exact Sciences | ||
| GENEDX | 78,64 | +9,18 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
| PROCEPT BIOROBOTICS | 93,60 | -0,90 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,240 | -0,37 % | Hims & Hers New Growth Category Is a Huge Surprise | ||
| INTUITIVE SURGICAL | 525,50 | -0,15 % | Intuitive Surgical-Aktie erreicht 52-Wochen-Hoch bei 552 US-Dollar | ||
| TALKSPACE | 3,450 | +4,23 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (-3,23 %) liegt der Kurs bei 0,003 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.
